Detalhe da pesquisa
1.
Controlling hepatitis C in Rwanda: a framework for a national response.
Bull World Health Organ
; 96(1): 51-58, 2018 Jan 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29403100
2.
Drug resistance mutations after the first 12 months on antiretroviral therapy and determinants of virological failure in Rwanda.
Trop Med Int Health
; 21(7): 928-35, 2016 07.
Artigo
Inglês
| MEDLINE | ID: mdl-27125473
3.
Effectiveness of early antiretroviral therapy initiation to improve survival among HIV-infected adults with tuberculosis: a retrospective cohort study.
PLoS Med
; 8(5): e1001029, 2011 May.
Artigo
Inglês
| MEDLINE | ID: mdl-21559327
4.
Exceptional genetic variability of hepatitis B virus indicates that Rwanda is east of an emerging African genotype E/A1 divide.
J Med Virol
; 81(3): 435-40, 2009 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-19152415
5.
High levels of adherence and viral suppression in a nationally representative sample of HIV-infected adults on antiretroviral therapy for 6, 12 and 18 months in Rwanda.
PLoS One
; 8(1): e53586, 2013.
Artigo
Inglês
| MEDLINE | ID: mdl-23326462
6.
Controlling hepatitis C in Rwanda: a framework for a national response
Bull. W.H.O. (Online)
; 96(1): 51-58, 2018. tab
Artigo
Inglês
| AIM | ID: biblio-1259914
7.
Prevalence of kidney disease in HIV-infected and uninfected Rwandan women.
PLoS One
; 6(3): e18352, 2011 Mar 28.
Artigo
Inglês
| MEDLINE | ID: mdl-21464937
8.
Weight loss after the first year of stavudine-containing antiretroviral therapy and its association with lipoatrophy, virological failure, adherence and CD4 counts at primary health care level in Kigali, Rwanda.
Trans R Soc Trop Med Hyg
; 104(12): 751-7, 2010 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-20889179
9.
When one can infect two: a reflection on the impact of HIV discordance on child HIV infection.
Pan Afr Med J
; 5: 10, 2010 May 10.
Artigo
Inglês
| MEDLINE | ID: mdl-21120009
10.
Stavudine- and nevirapine-related drug toxicity while on generic fixed-dose antiretroviral treatment: incidence, timing and risk factors in a three-year cohort in Kigali, Rwanda.
Trans R Soc Trop Med Hyg
; 104(2): 148-53, 2010 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-19732926
11.
Adult clinical and immunologic outcomes of the national antiretroviral treatment program in Rwanda during 2004-2005.
J Acquir Immune Defic Syndr
; 52(1): 49-55, 2009 Sep 01.
Artigo
Inglês
| MEDLINE | ID: mdl-19617847
12.
Controlling hepatitis C in Rwanda: a framework for a national response
Bull. W.H.O. (Print)
; 96(1): 51-58, 2018-1-01.
Artigo
Inglês
| WHOLIS | ID: who-272219
13.
Adherence to first-line antiretroviral regimens in Rwanda.
J Acquir Immune Defic Syndr
; 40(1): 113-4, 2005 Sep 01.
Artigo
Inglês
| MEDLINE | ID: mdl-16123694
14.
Tuberculosis in Rwanda: challenges to reaching the targets
Bull. W.H.O. (Print)
; 85(5): 383-384, 2007-5.
Artigo
Inglês
| WHOLIS | ID: who-270059